GE HealthCare reports first quarter 2026 financial results

About this update from Ge Healthcare Technologies Inc.

[{"type":"list","items":[{"val":[{"type":"text","content":"Revenue growth of 7.4%, including Organic revenue growth* of 2.9%","length":65,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Total orders up 1.1% organically versus 10.3% growth in the year-ago period; book-to-bill of 1.07 times and backlog of $21.8 billion","length":132,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Profitability in the quarter was impacted by a discrete PDx supplier issue that has since been resolved","length":103,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net income margin of 7.6% and Adjusted earnings before interest and taxes (EBIT) margin* of 13.5%; diluted earnings per share (EPS) of $0.85 and Adjusted EPS* of $0.99","length":167,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Cash flow from operating activities of $290 million and Free cash flow* of $112 million","length":87,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"For the full-year 2026, Company reaffirms topline growth driven by healthy global end market demand; reduces profit and Free cash flow* outlook as assumptions for inflation became more pronounced during the quarter; including inflation impact, expect to deliver mid- to high-single digit Adjusted EPS* growth","length":308,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":862,"olType":false},{"type":"text","content":"CHICAGO, April 29, 2026--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2026.","length":147,"tagName":"p"},{"type":"text","content":"GE HealthCare President and CEO Peter Arduini said, "As we start the year, we’re pleased with topline performance, which came in at the high end of our expectations. Growth was driven by strong commercial execution in Pharmaceutical Diagnostics, including Flyrcado, Advanced Visualization Solutions, and Imaging, as well as services. We are maintaining our topline growth guidance driven by healthy customer demand globally.","length":429,"tagName":"p"},{"type":"text","content":""Profitability in the first quarter was impacted by a PDx supplier issue that has since been resolved. We saw significant increases in memory chips, oil and freight costs during the first quarter that we assume will impact the rest of 2026. Given these d...

More updates from Ge Healthcare Technologies Inc.